Literature DB >> 30348663

OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.

Yunxing Yang1,2, Qingye Xu1,2, Tingting Li1,3, Ying Fu4, Yue Shi1,2, Peng Lan5, Dongdong Zhao1, Qiong Chen6, Zhihui Zhou1, Yan Jiang1,2, Anton Y Peleg7,8, Yunsong Yu9,2.   

Abstract

Entities:  

Keywords:  Acinetobacter baumanniizzm321990; OXA-23; resistance mechanism; sulbactam

Mesh：

Substances：

Year:  2018        PMID： 30348663      PMCID： PMC6325231          DOI： 10.1128/AAC.01676-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Purification and characterization of OXA-23 from Acinetobacter baumannii.

Authors:  Sinem Torol; Murat Kasap
Journal:  J Enzyme Inhib Med Chem       Date:  2012-05-31       Impact factor: 5.051

Review 2.  Confronting multidrug-resistant Acinetobacter baumannii: a review.

Authors:  Ioannis K Neonakis; Demetrios A Spandidos; Efthimia Petinaki
Journal:  Int J Antimicrob Agents       Date:  2010-12-04       Impact factor: 5.283

3.  Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China.

Authors:  Yunxing Yang; Ying Fu; Peng Lan; Qingye Xu; Yan Jiang; Yan Chen; Zhi Ruan; Shujuan Ji; Xiaoting Hua; Yunsong Yu
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 4.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.

Authors:  William F Penwell; Adam B Shapiro; Robert A Giacobbe; Rong-Fang Gu; Ning Gao; Jason Thresher; Robert E McLaughlin; Michael D Huband; Boudewijn L M DeJonge; David E Ehmann; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

6.  Multiplication of blaOXA-23 is common in clinical Acinetobacter baumannii, but does not enhance carbapenem resistance.

Authors:  Xiaoting Hua; Jianfeng Shu; Zhi Ruan; Yunsong Yu; Ye Feng
Journal:  J Antimicrob Chemother       Date:  2016-08-05       Impact factor: 5.790

7.  TEM-1 β-lactamase as a source of resistance to sulbactam in clinical strains of Acinetobacter baumannii.

Authors:  Lenka Krizova; Laurent Poirel; Patrice Nordmann; Alexandr Nemec
Journal:  J Antimicrob Chemother       Date:  2013-07-09       Impact factor: 5.790

8.  The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems.

Authors:  Eun-Jeong Yoon; Jung Ok Kim; Ji Woo Yang; Hwa Su Kim; Kwang Jun Lee; Seok Hoon Jeong; Hyukmin Lee; Kyungwon Lee
Journal:  J Antimicrob Chemother       Date:  2017-10-01       Impact factor: 5.790

9.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014.

Authors:  F-P Hu; Y Guo; D-M Zhu; F Wang; X-F Jiang; Y-C Xu; X-J Zhang; C-X Zhang; P Ji; Y Xie; M Kang; C-Q Wang; A-M Wang; Y-H Xu; J-L Shen; Z-Y Sun; Z-J Chen; Y-X Ni; J-Y Sun; Y-Z Chu; S-F Tian; Z-D Hu; J Li; Y-S Yu; J Lin; B Shan; Y Du; Y Han; S Guo; L-H Wei; L Wu; H Zhang; J Kong; Y-J Hu; X-M Ai; C Zhuo; D-H Su; Q Yang; B Jia; W Huang
Journal:  Clin Microbiol Infect       Date:  2016-03       Impact factor: 8.067

10.  Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii.

Authors:  Shu-Chen Kuo; Yi-Tzu Lee; Tsai-Ling Yang Lauderdale; Wei-Cheng Huang; Ming-Fen Chuang; Chien-Pei Chen; Shey-Chiang Su; Kuan-Rong Lee; Te-Li Chen
Journal:  Front Microbiol       Date:  2015-03-25       Impact factor: 5.640
View more
  11 in total

1.  Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii.

Authors:  Qingye Xu; Tao Chen; Biyong Yan; Linyue Zhang; Borui Pi; Yunxing Yang; Linghong Zhang; Zhihui Zhou; Shujuan Ji; Sebastian Leptihn; Murat Akova; Yunsong Yu; Xiaoting Hua
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 2.  Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat.

Authors:  David A Butler; Mark Biagi; Xing Tan; Samah Qasmieh; Zackery P Bulman; Eric Wenzler
Journal:  Curr Infect Dis Rep       Date:  2019-11-16       Impact factor: 3.725

3.  Beta-Lactamase Gene Expression Level of Hospital-Acquired CRAB Isolated from Children in Picu.

Authors:  Xiao Xu; Caifang Xu; Rabiu Bilya Salisu; Wei Xu
Journal:  Infect Drug Resist       Date:  2021-08-16       Impact factor: 4.003

4.  Escherichia coli Sequence Type 457 Is an Emerging Extended-Spectrum-β-Lactam-Resistant Lineage with Reservoirs in Wildlife and Food-Producing Animals.

Authors:  Steven P Djordjevic; Monika Dolejska; Kristina Nesporova; Ethan R Wyrsch; Adam Valcek; Ibrahim Bitar; Khin Chaw; Patrick Harris; Jaroslav Hrabak; Ivan Literak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  Therapeutic drug monitoring-guided high dose meropenem therapy of a multidrug resistant Acinetobacter baumannii - A case report.

Authors:  U Liebchen; M Paal; J Jung; I Schroeder; L Frey; M Zoller; C Scharf
Journal:  Respir Med Case Rep       Date:  2019-11-12

6.  Sulbactam Enhances in vitro Activity of β-Lactam Antibiotics Against Acinetobacter baumannii.

Authors:  Leilei Wang; Yuancheng Chen; Renru Han; Zhiwei Huang; Xuefei Zhang; Fupin Hu; Fan Yang
Journal:  Infect Drug Resist       Date:  2021-09-28       Impact factor: 4.003

7.  Molecular epidemiology and carbapenem resistance characteristics of Acinetobacter baumannii causing bloodstream infection from 2009 to 2018 in northwest China.

Authors:  Yihai Gu; Wei Zhang; Jine Lei; Lixia Zhang; Xuan Hou; Junqi Tao; Hui Wang; Minghui Deng; Mengrong Zhou; Rui Weng; Jiru Xu
Journal:  Front Microbiol       Date:  2022-08-22       Impact factor: 6.064

8.  Bacterial Genome Wide Association Studies (bGWAS) and Transcriptomics Identifies Cryptic Antimicrobial Resistance Mechanisms in Acinetobacter baumannii.

Authors:  Chandler Roe; Charles H D Williamson; Adam J Vazquez; Kristen Kyger; Michael Valentine; Jolene R Bowers; Paul D Phillips; Veronica Harrison; Elizabeth Driebe; David M Engelthaler; Jason W Sahl
Journal:  Front Public Health       Date:  2020-09-02

9.  Key Takeaways From the U.S. CDC's 2019 Antibiotic Resistance Threats Report for Frontline Providers.

Authors:  Sameer S Kadri
Journal:  Crit Care Med       Date:  2020-07       Impact factor: 7.598

10.  A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates.

Authors:  Fernando Pasteran; Jose Cedano; Michelle Baez; Ezequiel Albornoz; Melina Rapoport; Jose Osteria; Sabrina Montaña; Casin Le; Grace Ra; Robert A Bonomo; Marcelo E Tolmasky; Mark Adams; Alejandra Corso; Maria Soledad Ramirez
Journal:  Antibiotics (Basel)       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.